Bionest and PMC Address Optimization of Personalized Medicine Coalition Strategies

Published: Jan 31, 2012

NEW YORK & PARIS--(BUSINESS WIRE)--Bionest Partners, a premier strategy and management consulting firm for life science industries, and a recognized leader in personalized medicine strategy consulting, announces the publication of an article in a supplement to the Dec. 23, 2011 issue of Science. The article, co-authored by Dr. Edward Abrahams, President of the Personalized Medicine Coalition (PMC), focuses on how best to optimize decision-making for personalized medicine research and development (R&D) and commercialization strategies.

Back to news